Methiocarb

Target genes for Methiocarb is obtained based on ToxCast assay component endpoints.
Chemical nameGene identifierToxCast assay component endpoint name
MethiocarbNACEETOX_H295R_PROG_up
MethiocarbESR1CEETOX_H295R_TESTO_dn
MethiocarbNACEETOX_H295R_ANDR_dn
MethiocarbNACEETOX_H295R_TESTO_dn
MethiocarbCCL26BSK_4H_Eotaxin3_down
MethiocarbCREB3ATG_CRE_CIS_up
MethiocarbCEBPBATG_C_EBP_CIS_up
MethiocarbCSF1BSK_CASM3C_MCSF_down
MethiocarbEGR1ATG_EGR_CIS_up
MethiocarbESR1TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2
MethiocarbESR1ATG_ERE_CIS_up
MethiocarbESR1ATG_ERa_TRANS_up
MethiocarbESR2TOX21_ERb_BLA_Antagonist_ratio
MethiocarbETS1ATG_Ets_CIS_dn
MethiocarbF3BSK_CASM3C_TissueFactor_down
MethiocarbNR3C1CEETOX_H295R_CORTIC_up
MethiocarbNR3C1CEETOX_H295R_11DCORT_dn
MethiocarbNR3C1CEETOX_H295R_DOC_up
MethiocarbHLA-DRABSK_3C_HLADR_down
MethiocarbHLA-DRABSK_CASM3C_HLADR_down
MethiocarbIRF1ATG_ISRE_CIS_dn
MethiocarbARCEETOX_H295R_TESTO_dn
MethiocarbARCEETOX_H295R_ANDR_dn
MethiocarbARTOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881
MethiocarbLDLRBSK_CASM3C_LDLR_down
MethiocarbESR1CEETOX_H295R_TESTO_dn
MethiocarbNACEETOX_H295R_TESTO_dn
MethiocarbARCEETOX_H295R_ANDR_dn
MethiocarbARCEETOX_H295R_TESTO_dn
MethiocarbNR3C2CEETOX_H295R_CORTIC_up
MethiocarbNR3C2CEETOX_H295R_DOC_up
MethiocarbNR3C2CEETOX_H295R_11DCORT_dn
MethiocarbMTF1ATG_MRE_CIS_up
MethiocarbNFIAATG_NFI_CIS_up
MethiocarbNFE2L2ATG_NRF2_ARE_CIS_up
MethiocarbNR4A2ATG_NURR1_TRANS_up
MethiocarbPAX6ATG_Pax6_CIS_up
MethiocarbPGRCEETOX_H295R_PROG_up
MethiocarbPGRCEETOX_H295R_OHPREG_dn
MethiocarbPGRTOX21_PR_BLA_Antagonist_ratio
MethiocarbPLAURBSK_CASM3C_uPAR_down
MethiocarbPOU2F1ATG_Oct_MLP_CIS_up
MethiocarbPPARAATG_PPRE_CIS_up
MethiocarbPPARDATG_PPRE_CIS_up
MethiocarbPPARGATG_PPARg_TRANS_up
MethiocarbPPARGATG_PPRE_CIS_up
MethiocarbPTENNVS_ENZ_hPTEN_Activator
MethiocarbPTGER2BSK_LPS_PGE2_down
MethiocarbRARAATG_DR5_CIS_up
MethiocarbRARBATG_DR5_CIS_up
MethiocarbRARGATG_DR5_CIS_up
MethiocarbRXRBATG_RXRb_TRANS_up
MethiocarbSELEBSK_3C_Eselectin_down
MethiocarbSOX1ATG_Sox_CIS_up
MethiocarbTFAP2AATG_AP_2_CIS_dn
MethiocarbTFAP2BATG_AP_2_CIS_dn
MethiocarbTHBDBSK_3C_Thrombomodulin_down
MethiocarbTSHRTOX21_TSHR_Agonist_ratio
MethiocarbVCAM1BSK_4H_VCAM1_down
MethiocarbVCAM1BSK_LPS_VCAM1_down
MethiocarbVCAM1BSK_3C_VCAM1_down
MethiocarbVCAM1BSK_CASM3C_VCAM1_down
MethiocarbVDRATG_VDR_TRANS_up
MethiocarbVDRATG_VDRE_CIS_up
MethiocarbNACEETOX_H295R_ANDR_dn
MethiocarbNACEETOX_H295R_TESTO_dn
MethiocarbXBP1ATG_Xbp1_CIS_up
MethiocarbTFAP2DATG_AP_2_CIS_dn
MethiocarbNR1I2ATG_PXR_TRANS_up
MethiocarbNR1I2ATG_PXRE_CIS_up
MethiocarbCD40BSK_SAg_CD40_down
MethiocarbCD40BSK_LPS_CD40_down
MethiocarbNR1I3TOX21_CAR_Agonist

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.